Symptomatology of depression and onset of cardiometabolic diseases − A 7-year follow-up study
Open Access
- 13 January 2026
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 133, 106285
Abstract
No abstract availableKeywords
Funding Information
- Universiteit Leiden
- ZonMw (916.14.023)
- Leids Universitair Medisch Centrum
This publication has 58 references indexed in Scilit:
- Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK BiobankThe American Journal of Human Genetics, 2023
- Metabolomic and inflammatory signatures of symptom dimensions in major depressionBrain, Behavior, and Immunity, 2022
- The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammationBrain, Behavior, and Immunity, 2021
- Linking atypical depression and insulin resistance-related disorders via low-grade chronic inflammation: Integrating the phenotypic, molecular and neuroanatomical dimensionsBrain, Behavior, and Immunity, 2021
- Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA studyBrain, Behavior, and Immunity, 2020
- Atypical depression and double depression predict new-onset cardiovascular disease in U.S. adultsDepression and Anxiety, 2017
- Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease2016
- The Netherlands Epidemiology of Obesity (NEO) study: study design and data collectionEuropean Journal of Epidemiology, 2013
- Long-term Risk for Depressive Symptoms After a Medical DiagnosisArchives of internal medicine (1960), 2005
- Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluationClinical Psychology Review, 1988